Comparing Cutaquig vs Hizentra
Cutaquig (immune globulin subcutaneous) | Hizentra (immune globulin subcutaneous) |
|
---|
Cutaquig (immune globulin subcutaneous) | Hizentra (immune globulin subcutaneous) |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Primary Immunodeficiency Syndrome. Cutaquig may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Primary Immunodeficiency Syndrome. Hizentra may also be used for purposes not listed in this medication guide. |
||||||||||||||||
More about Cutaquig (immune globulin subcutaneous) | More about Hizentra (immune globulin subcutaneous) | ||||||||||||||||
Ratings & Reviews | |||||||||||||||||
Be the first to share your experience with this drug. |
Hizentra has an average rating of 6.7 out of 10 from a total of 34 ratings on Drugs.com. 53% of reviewers reported a positive effect, while 26% reported a negative effect. |
||||||||||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
View all Cutaquig side effects |
View all Hizentra side effects |
||||||||||||||||
Drug Class | |||||||||||||||||
Generic Availability | |||||||||||||||||
N/A |
N/A |
||||||||||||||||
Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Cutaquig prices |
View all Hizentra prices |
||||||||||||||||
Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
Brand Names | |||||||||||||||||
Other immune globulin subcutaneous brands include: Cuvitru, Hizentra, Xembify | Other immune globulin subcutaneous brands include: Cutaquig, Cuvitru, Xembify | ||||||||||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
564 hours |
564 hours |
||||||||||||||||
CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | |||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | |||||||||||||||||
A total of 23 drugs are known to interact with Cutaquig:
|
A total of 23 drugs are known to interact with Hizentra:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
Disease Interactions | |||||||||||||||||
First Approval Date | |||||||||||||||||
N/A |
N/A |
||||||||||||||||
WADA Class View classifications | |||||||||||||||||
N/A |
N/A |
||||||||||||||||
More Information | |||||||||||||||||
Patient Resources | |||||||||||||||||
Professional Resources | |||||||||||||||||
Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.